Fig. 4 | Signal Transduction and Targeted Therapy

Fig. 4

From: An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma

Fig. 4

Study flow. The study was performed in multiple institutions, including Guangdong (Sun Yat-sen University Cancer Center), Beijing (National Cancer Center), Zhengzhou (the Affiliated Cancer Hospital of Zhengzhou University), and Anyang (the Anyang Cancer Hospital). pCR pathological complete response, <pCR less than pCR, qPCR real-time quantitative polymerase chain reaction, FLDA Fisher’s linear discriminant analysis

Back to article page